Status
Conditions
Treatments
About
RAT is an innovative approach that includes intensive, repeatable, interactive and personalized applications.The aim of tihis study is to investigate the effect of robotic hand therapy added to conventional rehabilitation on rehabilitation outcomes in stroke patients.
Full description
Effective therapy in stroke rehabilitation should include repetitive, functional and task-specific exercises with high intensity and duration. In this context, in addition to traditional treatments, many new treatment approaches have come up in recent years. Robot-assisted therapy (RAT) is one of these new treatment approaches. RAT is an innovative approach that includes intensive, repeatable, interactive and personalized applications. It is seen that robotic systems are very suitable for the patient to receive more intense and task-oriented motor training by integrating with other rehabilitation approaches. Considering the scarcity of studies on robotic hand therapy, it was seen that larger scale and long-term studies are needed. In this study, investigators aimed to investigate the effect of robotic hand therapy added to conventional rehabilitation on motor functions and quality of life in stroke patients. Patients will be evaluated pretreatment, posttreatment and 3 months later after treatment. Evaluation parameters consist of Brunnstrom Staging, Modified Ashworth Scale (MAS), Fugl Meyer Assessment of The Upper Extremity, Functional Independence Measure Scale (FIM) and ABILHAND Questionnaire, Stroke Impact Scale (SIS), Stroke-Specific Quality of Life Scale (SS-QOL) and SF-36 Quality of Life Questionnaire. We think that robot-assisted therapy will contribute to the improvement of hand functions and quality of life in stroke patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Unilateral stroke
Between 4 weeks and 6 months after stroke
health status was suitable for rehabilitation
who could understand commands with a mini mental test score of 15 and above
who had Brunnstrom grade 3 and below (≤3).
Exclusion criteria
Patients with persistent upper extremity pain on the hemiplegic side (VAS>40)
Patients with severe spasticity in the hand (MAS≥3)
Patients with contractures in the hand
Patients who had fractures or operations on the hemiplegic side in the last 6 months
Patients who received botulinum toxin injection to the upper extremity in the last 6 months
Patients with skin ulcers
Patients with brain stem or cerebellar lesions
Patients with neglect or apraxia
Patients with severe visual impairment and severe depression
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal